ABT-288 Uses, Dosage, Side Effects and more
ABT-288 is under investigation in clinical trial NCT01018875 (Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease).
Trade Name | ABT-288 |
Generic | ABT-288 |
Type | |
Formula | C23H24N4O |
Weight | Average: 372.472 Monoisotopic: 372.195011409 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |